BioSpace News Archive

Verona Pharma plc, announces that senior management will present a company overview at the following conferences in November 2023.

Araris Biotech AG announced they have entered a collaboration agreement under which Araris will use its proprietary linker-conjugation platform to generate novel ADCs against undisclosed targets provided by Taiho Pharmaceutical Co., Ltd., a Japanese R&D-driven specialty pharma company with a focus on oncology.

Photocure ASA reported Hexvix®/Cysview® revenues of NOK 107.3 million in the third quarter of 2023, and an EBITDA of NOK 3.3 million for the company.

Nemysis is pleased to announce that it has entered into a Strategic Alliance Agreement with Bruno Farmaceutici S.p.A. for the mutual advancement of the portfolio and sales of each company.

TLC BioSciences announced that the Abstract Selection Committee of the American College of Rheumatology has accepted TLC’s late-breaking abstract on TLC599 for oral presentation at ACR Convergence 2023.

RetinalGeniX™ Technologies Inc. announced that it has contracted with Avania CRO to provide guidance for the Company’s interactions with the FDA for the development of RTG-2023 for the treatment of dry age-related macular degeneration and RTG-2024 for the treatment of Alzheimer’s syndrome dementia, and the RetinalCam™ image visualization device.

Attributes 2047% Revenue Growth to Companies Moving Away From Costly Data and Operation Silos

BeiGene, Ltd. announced that the Company will participate in the Jefferies London Healthcare Conference on Wednesday, November 15th, 2023 with a fireside chat at 2:00 pm GMT.

BIOLASE, Inc., the global leader in dental lasers, announced groundbreaking findings from a 12-month follow-up to a clinical trial performed at The McGuire Institute™.

Sage Therapeutics, Inc. announced that the Company will present at the following upcoming investor conferences in November.